Shanghai Pioneer Holding Ltd (HKG:1345)

Hong Kong · Delayed Price · Currency is HKD

1.985

-0.085 (-4.11%)

Oct 22, 2026, 3:59 PM HKT

Market Cap	2.30B +1.3%
Revenue (ttm)	1.43B -8.9%
Net Income	142.06M +18.3%
EPS	0.12 +19.4%
Shares Out	1.16B
PE Ratio	16.07
Forward PE	n/a
Dividend	0.12 (6.29%)
Ex-Dividend Date	Nov 19, 2026

Volume	24,000
Open	2.000
Previous Close	2.070
Day's Range	1.985 - 2.000
52-Week Range	1.900 - 2.400
Beta	-0.19
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Shanghai Pioneer Holding

Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, and imported in-licensed prescr... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 1996

Employees 448

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1345

Full Company Profile

Financial Performance

In 2025, Shanghai Pioneer Holding's revenue was 1.28 billion, a decrease of -16.17% compared to the previous year's 1.53 billion. Earnings were 114.38 million, a decrease of -24.56%.

Financial numbers in CNY Financial Statements